Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial - Concepedia

Concepedia

Publication | Closed Access

Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial

863

Citations

17

References

2013

Year

John J. Bissler, J.C. Kingswood, Elżbieta Radzikowska, Bernard A. Zonnenberg, Michael Frost, Matthias Sauter, Norio Nonomura, Susanne Brakemeier, Petrus J. de Vries, Vicky Whittemore,

Tuberous Sclerosis ComplexSporadic LymphangioleiomyomatosisPathologyPlacebo-controlled TrialSclerodermaMedicineTuberous Sclerosis

References

	Year	Citations

Page 1